Though no difference in the prevalence of cardiovascular disease (p = 0.56) and diabetes (p = 0.92) across each IMD centile, socioeconomically disadvantaged people also tended to be prescribed more of the cardiovascular medicines including ACE inhibitors and calcium-channel blockers, statins, beta-blockers and oral anticoagulants, whose risks can outweigh the benefits in later life [60, 64–66]. The gene discussed is ACE; the disease is diabetes mellitus.